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Abstract
Facial hyperpigmentation is the term used to express areas on irregular pigmen-
tation in the skin. It appears as darkened patches on the face that make the facial 
skin look uneven. Facial hyperpigmentation is not physically debilitating but has 
been associated with enhanced psychosocial complications including anger, depres-
sion and frustration. These psychosocial burdens, in turn, have inference on quality 
of life and self-esteem. So, the treatment of facial hyperpigmentation seems to be a 
growing concern to the dermatologists today and they have been practising several 
treatment modalities including chemical peeling, laser therapy, dermabrasion, etc. 
But, those are found to be associated with various after-effects. Hence, the use of 
plants and its products is highly recommended as they are reported with either none 
or fewer after-effects. The present chapter draws attention to the forms of facial 
hyperpigmentation with their aetiologies and available treatment options for them 
with associated side effects. Furthermore, we have discussed about the other side 
of treatment with herbal ingredients which are safe and have less or no side effects. 
This chapter will be of value to the dermatologists who are searching for naturally 
derived ingredients for treating facial hyperpigmentation, in line with consumer 
expectations and preferences.
Keywords: hyperpigmentation, psychosocial, treatment modalities, etiology,  
herbal ingredients, novel agents
1. Introduction
Melanin is the natural polymer pigment responsible for imparting color to the 
skin, hair, and eyes as well as provides the photoprotection of the skin against 
ultraviolet radiation. It is produced inside the specialized organelles, melanosomes 
of melanocytes through a complex process called melanogenesis. Although melanin 
protects the skin from UVB radiation damage, its overproduction leads to the prob-
lem of hyperpigmentation and its related disorders. Post-inflammatory disorders, 
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ephelides, solar lentigines, melasma, etc. are the common diseases of hyperpig-
mentation. Skin color imperfection due to hyperpigmentation spots on the face 
causes psychological problems in patients and takes them far from their social life. 
The public perceptions of tanned skin as being healthy and attractive merged with 
growing demand of treatment of facial hyperpigmentation provoke huge interest 
cosmeceutically as well as pharmaceutically [1–4].
Facial hyperpigmentation is a common and emergent concern to the dermatolo-
gists today. Treatment for facial hyperpigmentation seems to be difficult as there is no 
universally accepted treatment for it, and also the efficiency of known active agents is 
different. Majority of reports concerning the treatment of the disease consist of small 
series of patients. So, it becomes challenging to evaluate the efficacy of variety of 
therapy. Moreover, there are various options, but some of them come under grow-
ing scrutiny, emphasizing the research into pathogenesis and treatment. Sunscreen, 
chemical peeling, laser therapy, dermabrasion, topical treatment, cosmetic camou-
flages, etc. are the different treatment modalities used to treat facial hyperpigmenta-
tion. Though they are very effective and instant treatment for hyperpigmentation, its 
long-term exposure causes various side effects. Persistent erythema, swelling, pain, 
allergic reactions, herpes recurrence, acne, dyspigmentation, etc. are some of the 
various after effects associated with these treatment strategies [5–7].
In opposition to the state of affairs with these treatment options, we have the 
other side with herbal treatment which are nowadays attaining importance due to 
their low cost and ease of use and are believed to be free from risk of handling them 
as well as scarcely pollute the environment. Consequently, a dermatological formula-
tion, including active ingredients of strictly natural origin, is designed by a variety of 
scientist to protect the skin from exogenous and endogenous harmful agents. There 
are many chemical reactions involving various enzymes that are engaged in melano-
genesis. So, there is a wide range of targets or mechanisms against which to screen 
for skin pigmentation control agents. Active compounds isolated from different 
plants inhibit melanogenesis with no cytotoxicity by different mechanisms including 
inhibition of tyrosinase and other related protein expressions, inhibition of tyrosi-
nase activity, inhibition of melanin dispersion and translocation, etc. [8–10].
Hence, the present chapter highlights the commonly occurring hyperpigmen-
tary diseases of the face and their aetiologies. The available treatment options for 
hyperpigmentation along with the problems associated with them. As there is vast 
flora available on earth which has valuable medicinal properties, they are used for 
the treatment of many incurable diseases. Consequently, plants and its products 
are used for the treatment of hyperpigmentation through different mechanisms of 
action. Various studies on the use of plants for hyperpigmentation treatment have 
also been discussed in the present chapter.
2. Biosynthesis of melanin
Melanin is the end product of complex multistep transformation of amino acid, 
L-tyrosine. It is the polymorphous and multifunctional biopolymer represented 
by eumelanin (brown-black melanin), pheomelanin (brown-red melanin), and 
allomelanin (nitrogen-free melanin). This can be differentiated on the basis of 
chemical composition and monomer subunit structure of melanin. It has been 
found that there are four factors involved in melanin formation: (1) tyrosine as 
substrate, (2) tyrosinase with its coenzyme, (3) molecular oxygen, and (4) dihy-
droxyphenylalanine (DOPA). Tyrosine is converted into melanin by a series of 
enzymatic reaction [11–13].
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Biosynthesis of melanin can be initiated from either the hydroxylation 
of L-phenylalanine to L-tyrosine or directly from L-tyrosine, which is then 
hydroxylated to L-dihydroxyphenylalanine (L-DOPA). In the next step, 
L-DOPA is oxidized to dopaquinone which is common to both eu- and phe-
omelanogenic pathways. Formation of eumelanin involves transformation 
of dopaquinone to leukodopachrome, followed by a series of oxidoreduction 
reactions. Dihydroxyindole (DHI) and DHI carboxylic acid (DHICA) are 
produced as intermediates, which undergo polymerization to form eumelanin. 
Pheomelanin synthesis also begins with dopaquinone; this is conjugated to 
cysteine or glutathione to yield cysteinyldopa and glutathionyldopa, for fur-
ther transformation into pheomelanin. Mixed melanin contains both eu- and 
pheomelanin [12, 14–18].
3. Hyperpigmentary diseases of the face and their etiology
Melanocytes are responsible for the synthesis and distribution of melanin 
pigment, by the process of melanogenesis which involves different stages from 
embryonic development, melanin synthesis, to its transfer to neighboring kerati-
nocytes. The importance of each of these stages and their mechanisms is evident in 
clinical defects in the form of hypopigmentation or hyperpigmentation. Exposure 
of the skin to UV radiation or other exo- and endogenous sources/allergen poses 
erythema, variation of vascular responses and immunosuppression, formation of 
inflammatory mediators, or overproduction of melanin which leads to pigmentary 
disorder, i.e. hyperpigmentation [19–21].
Facial hyperpigmentation is a common and growing concern to the dermatolo-
gists today. The difference in structure and function of the skin, as well as the influ-
ence of cultural practices, produces variable skin diseases of the face based on skin 
type. There are many skin conditions quite unique to person skin of color. Some of 
them are summarized here.
3.1 Postinflammatory hyperpigmentation
Postinflammatory hyperpigmentation (PIH) refers to the darkening 
of the skin that arises after cutaneous injury or inflammatory eruption. 
Hyperpigmentation results from the melanocyte’s response to the cutaneous 
insult, which causes increased production of melanin. Acne lesions, scratches, 
insect bites, ingrown hairs, etc. are among such cutaneous insults. It has been 
found that patients of darker skin are more susceptible to this pigment altera-
tion. Postinflammatory changes can occur both in the epidermis and dermis 
of the skin. In epidermal hyperpigmentation, there is an increase in melanin 
production and/or its transfer to keratinocytes. In dermal postinflammatory 
hyperpigmentation, a damaged basement membrane allows melanin to enter the 
dermis, which is then phagocytosed by dermal macrophages, called as melano-
phages. Macrophages may also migrate into the epidermis, phagocytose mela-
nosomes, and then return to the dermis. Melanin within dermal melanophages 
may persist for years [22–25].
Physical examination of PIH includes small to large hyperpigmented macules 
and patches of variable size in any distribution. The time required for the normal-
ization of dyspigmentation is unpredictable and depends on many factors including 
the patient’s baseline skin tone, the type and intensity of the injury or inflamma-
tion, and the patient’s sun exposure habits [22, 24].
Depigmentation
4
3.2 Maturational dyschromia
It has been observed as darkening of facial skin tone, even outside of extensive 
sun exposure and sometimes termed as general uneven tone. Maturational dyschro-
mia can be described as diffuse hyperpigmentation usually occurs on the lateral 
forehead and cheek bones. According to one of the survey-based studies, more than 
one third of black women have complaint of uneven skin tone. These alterations in 
skin tone are possibly due to chronic sun exposure over many years. Maturational 
dyschromia may be misdiagnosed as melasma, acanthosis nigricans, or postinflam-
matory hyperpigmentation [26].
3.3 Ephelides
Ephelides, or freckles, are caused by an increase in photoinduced melanogen-
esis and increase in transport of fully melanized melanosomes from melanocytes 
to keratinocytes. It occurs on sun-exposed area of the body, predominantly the 
face, dorsal side of hands, and trunk. They are 1–3 mm hyperpigmented macules 
that are round, oval, or irregular in shape. They might increase in number and 
distribution but can fade with aging. Ephelides are benign and there is no tendency 
of it to transform into malignant. Ephelides are benign and show no susceptibil-
ity for malignant transformation. Some ephelides represent as a subtype of solar 
lentigo [27, 28].
3.4 Lentigines
Lentigines are found more commonly in white subjects including African-
Americans and American-Indians. Individuals of skin type I and III are more likely 
to develop solar lentigines. Solar lentigines result from a local propagation of basal 
melanocytes and a consequent increase in melanization, differing from freckles, 
which result from increased melanin production. Like ephelides, they also occur in 
sun-exposed areas, particularly the dorsal side of hands and forearms, face, upper 
back, and chest. Solar lentigines are 2–3 cm well circumscribed, round, oval, or 
irregularly shaped macules that differ in color from tan to dark brown [29, 30].
3.5 Melasma
Melasma is a common and well described form of hyperpigmentation that is 
seen most commonly on the face. It is a common disorder of hyperpigmentation 
affecting millions worldwide and at least 90% of those are females. It predomi-
nantly affects women with darker skin types, i.e. Fitzpatrick skin phototypes III 
and IV. It has also been referred to as chloasma or ‘the mask of pregnancy’ because 
the condition is often associated with pregnant women. There is recently no exact 
etiology, but multiple factors like ultraviolet radiation, hormonal alteration, genetic 
predisposition, and/or inflammation have all been involved. Physical examination 
of the disease includes light to dark-brown patches with irregular margins usually 
distributed symmetrically on the centrofacial, malar, and mandibular regions and 
can also be seen on the forearms [31].
On the basis of location of melanin, melasma can be differentiated into epider-
mal, dermal, mixed, and indeterminate types. In epidermal type, the pigment is 
brown, and borders are well defined, whereas in the dermal type pigment is gray 
brown, and borders are scantily defined. When there is melanin in both epidermis 
and dermis, mixed-type melasma occurs, and the term interdeterminate type may 
be used when it is not easy to classify even with the aid of Wood’s light [32].
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3.6 Lichen planus pigmentosus
Lichen planus pigmentosus is an unusual variant of lichen planus common in indi-
vidual with skin types III and IV. It affects young to middle-aged adults generally those 
from India, Latin America, and the Middle East. Clinically, there are oval or irregular 
gray-brown to brown macules or patches with usually diffused and symmetrical 
pattern on sun-exposed areas, including the forehead, and neck, or intertriginous 
areas. Lesions are often symmetrical and can present in unilateral, linear fashion. The 
etiology for the disease is unknown, but immunological mechanisms associated with 
cellular immunity and exposure to ultraviolet light appear to be concerned [33, 34].
4. Treatment strategies for facial hyperpigmentation
Treatment for facial hyperpigmentation seems to be challenging as there is no 
universally accepted therapy for it, and also the efficacy of existing agents is dif-
ferent. Majority of reports regarding treatment consist of small series of patients, 
so it is difficult to evaluate the efficacy of a variety of therapies. Additionally, there 
are multiple options available, but some of them come under increasing scrutiny, 
underscoring the requirement of research into pathogenesis and treatment. On the 
whole, treatment includes removal of provoking factors, photoprotection, and active 
pigment reduction with either topical formulations or physical approaches [35, 36].
4.1 Sunscreen
Numerous evidence-based studies showed that light from both UV and visible 
spectrum can induce variation in pigmentation pattern of the skin. Both UVA and 
UVB cause increased melanin synthesis resulting in delayed tanning. Sun protection 
is found to be the most significant step which has to be taken to prevent and to cure 
hyperpigmentation. So, broad spectrum UVA and UVB protective sunscreen with 
SPF of at least 30 including a physical block (e.g. titanium dioxide and zinc oxide) 
should be recommended in order to protect the skin from hyperpigmentation [37, 38]. 
It has been observed that the use of broad spectrum sunscreen on the first day after 
skin resurfacing can decrease the incidence of postinflammatory hyperpigmentation 
after laser treatment [39].
4.2 Cosmetic camouflage
Cosmetic camouflage is the application of makeup including cream and powder 
to conceal color. Physical blocking opaque sunscreens also have camouflage facial 
hyperpigmentation and prevent photoinduced darkening. Many patients find that 
the use of makeup helps even out skin tone. Moreover cosmetic camouflage solves 
the psychological problems that a skin imperfection is sometimes able to irritate; 
it allows to rejuvenate its own beauty and to return to its own social life [40]. A 
single-centre clinical trial was conducted by Roberts et al. on females with mild to 
moderate facial hyperpigmentation to assess the efficacy of multifunctional facial 
primer. They found it very effective for immediate or long-term improvement of 
hyperpigmentation when used over a period of 12 weeks [41].
4.3 Chemical peel
Chemical peels can be used for the treatment of facial hyperpigmentation either 
alone or combined with other regimens. Most common chemicals used for peeling 
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are trichloroacetic acid, phenol, lactic, glycolic acid, retinoid, etc. In this technique, 
a chemical solution is applied to the skin which makes it exfoliate and ultimately 
peel off; it means it damages the skin in a controlled manner. Finally the newer skin 
appears with no hyperpigmentary spots. After chemical peel, the skin becomes 
more sensitive to sun, so the use of sunscreen is recommended. Generally, there are 
three types of chemical peels based on the depth of the skin they exfoliate: super-
ficial peel, medium peel, and deep peel. In superficial peel, mild acids like alpha 
hydroxy acids are used to exfoliate the skin. It only penetrates the outermost layer 
of the skin. Trichloroacetic acid or glycolic acids are used in medium peel to remove 
damaged skin; they reach to the middle and outer layer of the skin. On the other 
hand, deep peels fully penetrate the middle layer of the skin. Medium-depth peel 
should be highly recommended and performed with caution, and deep peels are 
not at all recommended because of the high risk of permanent pigmentary changes. 
Although chemical peeling may help in improving facial hyperpigmentation, they 
can also cause irritation which leads to dyspigmentation [42].
4.4 Dermabrasion
Dermabrasion is the non-chemical superficial removal of the upper skin 
with abrasive tool. Patients with resistant melasma, especially with well-known 
dermal components that are hard to treat, have been successfully treated with 
dermabrasion. Methods with the use of 16-mm diameter coarse grit diamond fraise 
are considered successful. Ninety seven percent of patients were found to have 
improvement, and only around 1% was found to develop hypertrophic scars or 
permanent hypopigmentation [43]. In most of the other cases, mild to moderate 
improvement has been shown with dermabrasion. Histopathologically, decreased 
melanization and regular distribution of melanosomes were commonly observed in 
biopsy samples of patients treated with dermabrasion [44].
4.5 Laser therapy
Laser and light therapy is a promising and effective treatment for a variety of 
hyperpigmentation conditions. In particular, longer wavelength is the most widely 
used laser because it can penetrate deeper and can target dermal pigments. Lasers and 
light sources should only be used by the experienced physician, and it should only be 
attempted after other modalities have been proven to be unsuccessful for a particular 
disorder. This treatment strategy however is quite challenging because of the high risk 
of damage to surrounding tissues that can lead to long-lasting and delayed postin-
flammatory hyperpigmentation. So, proper patient counseling with regard to side 
effects, and expectations should always be done prior to any laser therapy [45, 46].
4.6 Topical treatment
The majority of topical agents used are those that disrupt the enzymatic 
processes of pigment production within melanocytes. Different agents like 
hydroquinone, kojic acid, arbutin, retinoids, etc. have been used either alone or 
in combination with varying degree of efficacies. Kligman formulation having 
combination of hydroquinone, tretinoin, and hydrocortisone has been used in 
many skin lightening creams. Modified combination of Kligman formulation has 
also been successfully tested by various scientists during their studies, and now they 
have been practised in various lightening creams. But continuous applications of 
these agents have been found to have certain side effects. Hydroquinone is the gold 
standard for the treatment of facial hyperpigmentation and has been used for many 
7On the Intricacies of Facial Hyperpigmentation and the Use of Herbal Ingredients as a Boon…
DOI: http://dx.doi.org/10.5772/intechopen.84257
years, but adverse reactions have been associated with hydroquinone, which include 
asymptomatic transient erythema, irritation, and exogenous ochronosis [47]. Kojic 
acid is a known sensitizer and can cause erythema and contact dermatitis. Similarly, 
arbutin at higher concentrations can cause paradoxical hyperpigmentation [48].
There are various national and international brands who are claiming that the 
skin will glow after a short period of time on topical application of their cream. 
They are claiming that their products are entirely safe as they are using herbal 
ingredients. But, it is not possible to make the skin glow and white in a short span 
of time without using harmful substances such as heavy metals. The Centre for 
Science and Environment (CSE) has reported that about half of the 73 national and 
international brands of popular cosmetics contain high levels of toxic heavy metals 
such as mercury, cadmium, etc. The CSE’s Pollution Monitoring Lab had tested 
popular fairness creams and found 44% mercury in it. According to Sunita Narain, 
director general of CSE, ‘Mercury is not supposed to be present in cosmetic prod-
ucts. Its mere presence in these products is completely illegal and unlawful [49]’.
5. Consequences of conventional treatment strategies
Although there are several modalities of treatment for facial hyperpigmenta-
tion available today including physical therapies or chemical agents, none of them 
are entirely satisfactory. Traditional topical agents like hydroquinone, kojic acid, 
arbutin, etc. are highly effective, but their long-term exposure causes several 
side effects. Persistent erythema, swelling, pain, allergic reactions, herpes recur-
rence, acne, dyspigmentation, etc. are some of the various after effects associated 
with treatment strategies like chemical peeling, dermabrasion, laser therapy, and 
cosmetic camouflage [50, 51].
There is a high risk of damage to the surrounding tissues when treated with 
laser therapy. During one of the clinical trials on woman patients, allergic reac-
tions have been reported when treated with chemical peel using tretinoin. Patients 
exhibited itching, swelling, and erythema on their entire face [52]. Though the use 
of sunscreen with 50+ SPF may protect the skin from sun tan, its long-term use 
significantly decreases the cutaneous vitamin D production which is necessary for 
bone health and hence increases the risk of osteoporosis [53].
6. Natural herbal-based treatment for hyperpigmentation
Due to the consequences of conventional treatment modalities for skin hyper-
pigmentation, scientists and dermatologists are now looking for the treatment 
which will be safe and having very less or no side effects as well as do not contami-
nate the environment. Thus, the use of herbs and their ingredients for skin hyper-
pigmentation treatment is gaining interest as they are found to be safer, milder, and 
healthier than synthetic products. Dermatological formulation, including active 
compounds of strictly natural origin, is designed to protect the skin from hyperpig-
mentation. The aim of using natural ingredients is to reduce skin hyperpigmenta-
tion without causing undesirable hypopigmentation and irritation in the skin [10].
As there are many processes and enzymes involved in melanogenesis, there is a 
wide range of targets or mechanisms against which to screen for skin pigmentation 
control agents. Active compounds extracted from different plants inhibit melano-
genesis without melanocyte toxicity by different mechanisms including inhibition 
of tyrosinase and other related protein expressions, inhibition of tyrosinase activity, 
inhibition of melanin dispersion, and translocation.
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6.1 Inhibition of tyrosinase activity
As tyrosinase is the key enzyme of melanogenesis, inhibitors of this enzyme have 
caught the interest of dermatologists to prevent abnormal accumulation of melanin. 
There are various botanical agents that are acting through interfering in the pathway 
leading to melanin synthesis by inhibiting the activity of tyrosinase [54].
p-Coumaric acid extracted from the fresh leaves of Panax ginseng was used 
to inhibit the oxidation of L-tyrosine catalysed by mushroom tyrosinase [55]. 
Epicatechin gallate, gallocatechin gallate, and epigallocatechin gallate were the 
three major components isolated from green tea, and their efficacy of the inhibition 
of mushroom tyrosinase was assessed and found that green tea was the strongest 
inhibitor. Kinetic analysis revealed that these components inhibit tyrosinase via 
competitive inhibition [56]. Similarly, studies of Hridya et al. [57] and Hridya et al. 
[58] demonstrated that brazilein isolated from Caesalpinia sappan and santalin 
isolated from Pterocarpus santalinus have been found to reversibly inhibit tyrosinase 
in a mixed-type manner. Both the compounds inhibited tyrosinase activity dose 
dependently.
Recently, Kim et al. [59] have isolated five flavonoids, kushenol A, 8-prenylkaemp-
ferol, kushenol C, formononetin, and 8-prenylnaringenin, from Sophora flavescens 
to find out compounds with inhibitory activity towards tyrosinase. They have tested 
the ability of these flavonoids to block the conversion of L-tyrosine to L-DOPA by 
tyrosinase. Among the five compounds, kushenol A and 8-prenylkaempferol exhibited 
potent inhibitory activity which was further confirmed by molecular docking analysis.
6.2 Inhibition of tyrosinase and other related protein expressions
To develop treatment therapies for hyperpigmentation, many natural products 
have been tested which aimed at inhibiting production and expression of enzymes 
involved in rate-limiting steps of melanogenesis pathway including tyrosinase, 
tyrosinase-related protein-1 (TRP-1), and tyrosinase-related protein-2 (TRP-2).
Macelignan isolated from Myristica fragrans has shown inhibitory action on 
melanogenesis and significantly decreased the expression of tyrosinase, tyrosinase-
related protein-1, and tyrosinase-related protein-2 expressions in melan-a murine 
melanocytes. Macelignan effectively inhibits melanin synthesis and thus could be 
used as a new skin whitening agent [60]. Panduratin A isolated from Kaempferia 
pandurata was also found to inhibit melanin biosynthesis. Through western blot 
analysis, panduratin A has shown decrease expression of tyrosinase, TRP-1, and 
TRP-2 proteins [61]. Similarly, curcumin suppressed the expression of melano-
genesis-related protein expression such as tyrosinase, TRP-1, TRP-2, and MITF in 
alpha-melanocyte-stimulating hormone (MSH)-stimulated B16F10 cells [62].
Panax ginseng is a medicinal herb, which contains various ginsenoside with 
therapeutic effects. Lee et al. [63] isolated floralginsenoside (FGA), ginsenoside 
Rd. (GRd), and ginsenoside Re (GRe) from Panax ginseng berry. Among the three, 
floralginsenoside (FGA) was observed to impart more inhibitory effect on melano-
genesis through decreased expression of microphthalmia-associated transcription 
factor in a dose-dependent manner. In addition to this, FGA also induced extracel-
lular signal-regulated kinase phosphorylation level in melan-a cells. Peng et al. 
[64] evaluated the antimelanogenic and depigmenting activity of 10-hydroxy-
2-decenoic acid (10-HDA) from royal jelly of Apis mellifera. They have reported 
that 10-hydroxy-2-decenoic acid (10-HDA) would reduce melanin biosynthesis 
through inhibiting the expression of tyrosinase, TRP-1, TRP-2, and MITF in B16F1 
melanoma cells.
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In a recent study, Ko et al. [65] investigated that n-hexane fraction of Sageretia 
thea downregulated melanogenesis through reduced expression of tyrosinase, 
TRP1, TRP2, and MITF. Bioactive compounds responsible for melanogenesis inhibi-
tion were identified through gas chromatography-mass spectrometry (GC-MS) 
analysis as methyl linoleate and methyl linolenate.
6.3 Inhibition of melanosome transfer to keratinocytes
Regulation of skin pigmentation depends on several processes. The transfer 
of melanosomes from melanocytes to keratinocytes is one of the major factors 
which play a crucial role in cutaneous pigmentation. Hence there are various 
treatment modalities developed to inhibit melanosome transfer in order to prevent 
hyperpigmentation.
Niacinamide, a derivative of vitamin B3, can be found in many foods including 
meat, milk, eggs, green vegetables, etc. Greatens et al. [66] found that niacina-
mide inhibits melanosome transfer to keratinocytes in cocultures of keratinocytes 
and melanocytes. They have assessed the effect of niacinamide on facial hyper-
pigmented spots through human clinical trials and observed the reduction of 
hyperpigmented lesion. Methylophiopogonanone B extracted from Ophiopogon 
japonicus also appeared to reduce melanosome transfer [67]. Similarly, centaureidin 
(5,7,3′-trihydroxy-3,6,4′-trimethoxyflavone) derived from Achillea millefolium also 
reduced melanosome transfer to keratinocytes. It was believed that centaureidin 
activates Rho which leads to melanocyte dendrite retraction without affecting mela-
nogenic enzyme expression [68].
7. Conclusion
Hyperpigmentation is a common condition characterized by patches or spots 
on the skin. Pigment spots appear mainly on body parts that are exposed and 
hence are more commonly found on face. Facial hyperpigmentation is not only 
the problem concerned with pharmaceuticals and cosmeceutical sciences, but it 
is a problem that can pressurized the beauticians also to find out its treatment. 
Besides of being a disease, it is also associated with psychosocial complications. 
So, the appropriate treatment for hyperpigmentation is the need of the day. There 
are various treatment modalities available in medical sciences in order to treat 
hyperpigmentation, but many of them come under increasing scrutiny due to 
the side effects they impart on the patient skin. Herbal ingredients on the other 
hand are free from side effects and can hardly contaminate the environment. 
Hence, they are used for the treatment of facial hyperpigmentation. Many plants 
and their products have been used successfully to treat hyperpigmentation. 
But still, there are infinite numbers of plants which are yet to be characterized 
for their efficacy to treat hyperpigmentary problems of the face. Scientists all 
over the world would therefore try to evaluate more potent agents using various 
state-of the-art techniques that are highly effective and safe for the treatment of 
hyperpigmentation.
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